Skip to content

English
Français

Careers
Contact Us

About DBV
- Overview
- Leadership
Our Pipeline
- Overview
- Clinical Trials
- VIASKIN^® peanut patch
- VIASKIN^® milk patch
- VIASKIN^® milk patch for EoE
- Expanded Access Program
Our Science
Investors
Newsroom
- Press Releases
- Media Kit

News

News

Select Year
Search News

Found 508 Results

Page 31 of 51« First «...10 20...29 303132 33...40 50...»Last »

November 14, 2017

DBV Technologies Announces Publication of Positive Data from Phase IIb Trial and Long-Term Study of Viaskin Peanut inthe Journal of the American Medical Association

October 31, 2017

DBV Technologies Reports September 30, 2017 Cash Position

October 20, 2017

DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut-Allergic Patients Four to 11 Years of Age

October 12, 2017

DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut

October 12, 2017

DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut

September 1, 2017

DBV Technologies to Attend Upcoming Investor Conferences

August 29, 2017

DBV Technologies Announces Completion of Enrollment in Phase III Extension Study of Viaskin Peanut

August 2, 2017

DBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-Allergic Patients One to Three Years of Age

July 28, 2017

DBV Technologies Reports First Half 2017 Financial Results

July 5, 2017

Half-Year Report on the DBV Technologies Liquidity Contract with Natixis

Page 31 of 51« First «...10 20...29 303132 33...40 50...»Last »

Investor Relations Contact

Jonathan Neely

+1 848-388-4584

jonathan.neely@dbv-technologies.com

Media Contact

Brett Whelan

+1 848-350-7622

brett.whelan@dbv-technologies.com

Subscribe to get the latest DBV press releases

About DBV
- Overview
- Leadership
Our Pipeline
Our Science
Investors
News
Careers
Contact Us
English
Français

About DBV
- Overview
- Leadership
Our Pipeline
Our Science
Investors
News
Careers
Contact Us
English
Français

Homepage
About DBV
Our Pipeline
Our Science
News
Investors
Careers
Contact Us

© 2026 DBV Technologies. All rights reserved.
Les traitements de DBV Technologies sont expérimentaux et ne sont pas approuvés par la FDA.

Terms of Use
Privacy Policy
Legal Notice
Cookies Policy

Scroll to Top